Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Genetic Information and Family Testing (GIFT) study: trial design and protocol.

BMC cancer - 27 Feb 2025

Katz Steven J, Abrahamse Paul, Hofer Tim P, Courser Rebecca R, Hodan Rachel, Tocco Rachel S, Rios-Ventura Sonia, Ward Kevin C, Hamilton Ann S, Kurian Allison W, An Lawrence C

Abstract excerpt

BACKGROUND: There is pressing need to develop and evaluate clinically sound approaches to supporting the engagement between patients who have inherited cancer susceptibility and their relatives who may share it. Identifying and engaging patients with an inherited cancer susceptibility in the community is a potentially powerful strategy to reduce the gap in genetic risk evaluation for their families. The goal of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Family
Share to Genetic Counseling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Multicenter Studies as Topic

Share to Neoplasms

Share to Randomized Controlled Trials as Topic

Share to Research Design

Source

Open in PubMed Open full text

Identifiers

PMID: 40016666
DOI: 10.1186/s12885-025-13744-6
PMCID: PMC11869684

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Genetic Information and Family Testing (GIFT) study: trial design and protocol.PMID 40016666Read ↗

Results From the Genetic Information and Family Testing Study: A Cluster-Randomized Trial.Semantic proximity Read ↗

Facilitated cascade testing (FaCT): a randomized controlled trial.Semantic proximity Read ↗

Family history and cancer risk study (FOREST): A clinical trial assessing electronic patient-directed family history input for identifying patients at risk of hereditary cancer.Semantic proximity Read ↗

Cascade Chatbot: A Scalable Approach to Family-Based Genetic Testing for Hereditary Cancer Syndromes.Semantic proximity Read ↗

ACT-ON: Assisted cascade testing via outreach and navigation - Real-world experience with clinician-facilitated cascade testing.Semantic proximity Read ↗

Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study.Semantic proximity Read ↗

IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.Semantic proximity Read ↗

Timely targeted testing for hereditary cancer syndromes - Importance of clinician-facilitated cascade testing in the first year post-diagnosis.Semantic proximity Read ↗

Choice architecture in cascade genetic testing (CHARGE study) for hereditary cancer: Design of a hybrid type I randomized feasibility trial.Semantic proximity Read ↗

An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial.Semantic proximity Read ↗

Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial.Semantic proximity Read ↗

Streamlining Inherited Cancer Identification via an EMR-Integrated Risk Assessment Platform: A Nonrandomized Clinical Trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.